BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2564809)

  • 1. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
    Jaggi R; Höck W; Ziemiecki A; Klemenz R; Friis R; Groner B
    Cancer Res; 1989 Apr; 49(8 Suppl):2266s-2274s. PubMed ID: 2564809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos.
    Touray M; Ryan F; Saurer S; Martin F; Jaggi R
    Oncogene; 1991 Feb; 6(2):211-7. PubMed ID: 1847998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
    Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
    Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M; Ryan F; Jaggi R; Martin F
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
    Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
    Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain.
    Bodwell JE; Kingsley LA; Hamilton JW
    Chem Res Toxicol; 2004 Aug; 17(8):1064-76. PubMed ID: 15310238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element.
    Rozansky DJ; Wu H; Tang K; Parmer RJ; O'Connor DT
    J Clin Invest; 1994 Dec; 94(6):2357-68. PubMed ID: 7989592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
    Cha HJ; Park MT; Chung HY; Kim ND; Sato H; Seiki M; Kim KW
    Oncogene; 1998 Feb; 16(6):771-8. PubMed ID: 9488041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
    Castillo AI; Tolon RM; Aranda A
    Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of cellular transformation by glucocorticoid receptor mutants.
    Kameda T; Iba H
    Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcription.
    Jaggi R; Friis R; Groner B
    J Steroid Biochem; 1988 May; 29(5):457-63. PubMed ID: 3379954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the 97 kDa glucocorticoid receptor to the 5' upstream flanking region of the mouse c-Ha-ras oncogene.
    Strawhecker JM; Betz NA; Neades RY; Houser W; Pelling JC
    Oncogene; 1989 Nov; 4(11):1317-22. PubMed ID: 2682459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone.
    Becker PB; Gloss B; Schmid W; Strähle U; Schütz G
    Nature; 1986 Dec 18-31; 324(6098):686-8. PubMed ID: 2879246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
    Li J; Johnson TA; Hanson LA; Beer DG
    Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock.
    Sanchez ER; Hu JL; Zhong S; Shen P; Greene MJ; Housley PR
    Mol Endocrinol; 1994 Apr; 8(4):408-21. PubMed ID: 8052262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
    Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
    Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product.
    Hermonat PL
    Cancer Res; 1991 Jul; 51(13):3373-7. PubMed ID: 1647267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.